SEARCH

SEARCH BY CITATION

References

  • Alfredsson R, Svensson E, Trollfors B, Borres MP. (2004) Why do parents hesitate to vaccinate their children against measles, mumps and rubella? Acta Pediatr 93:12321237.
  • American Academy of Pediatrics Committee on Infectious Diseases. (1996) The relationship between pertussis vaccine and central nervous system sequelae: continuing assessment. Pediatrics 97:279281.
  • Ball R, Halsey N, Miles Braun M, Moulton LH, Gale AD, Rammohan K, Wiznitzer M, Johnson R, Salive ME, the VAERS Working Group. (2002) Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System. J Clin Epidemiol 55:819824.
  • Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mulloly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, for the Centers for Disease Control, Prevention Vaccine Safety Datalink Working Group. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345:656661.
  • Berg AT. (2007) Vaccines, encephalopathies and mutations. Epilepsy Curr 7:4042.
  • Berkovic SF, Harkin L, McMahon JM, Pelekanos JT, Zuberi SM, Wirrell EC, Gill DS, Iona X, Mulley JC, Scheffer IE. (2006) De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 5:488492.
  • Black S, Eskola J, Siegrist CA, Halsey N, MacDonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C. (2009) Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 infl uenza vaccines. Lancet 374:21152222.
  • Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, Halsey N, Vermeer P. (2004) The Brighton Collaboration Seizure Working Group. Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22:557562.
  • Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl K, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R. (2009) The Brighton Collaboration Methods Working Group. Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems. Vaccine 27:22892297.
  • Brown NJ, Berkovic SF, Scheffer IE. (2007) Vaccination, seizures and ‘vaccine damage.’ Curr Opin Neurol 20:181187.
  • Cendes F, Sankar R. (2011) Vaccinations and febrile seizures. Epilepsia 52(Suppl. 3):2325.
  • Centers for Disease Control and Prevention. (2008) Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep 57:258260.
  • Centers for Disease Control and Prevention. (2010) Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010–11. MMWR Morb Mortal Wkly Rep 59:989992.
  • Cody CL, Baraff LJ, Cherry JD, Marcy SM, Manclark CR. (1981) Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 68:650660.
  • Committee on Infectious Diseases. (2011) Policy Statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children. Pediatrics 128:630632.
  • David S, Vermeer-de Bondt PE, van der Maas NAT. (2008) Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in Netherlands. Vaccine 26:58835887.
  • Davis RL, Barlow W. (2003) Placing the risk of seizures with pediatric vaccines in a clinical context. Pediatri Drugs 5:712722.
  • Derrough TF, Kitchin NRE. (2002) Occurrence of adverse events following inadvertent administration of childhood vaccines. Vaccine 21:5359.
  • Doja A. (2008) Genetics and the myth of vaccine encephalopathy. Paediatr Child Health 13:7599.
  • Ellenberg SS, Foulkes MA, Midthun K, Goldenthal KL. (2005) Evaluating the safety of new vaccines: summary of a workshop. Am J Public Health 95:800807.
  • Farrington CP, Nash J, Miller E. (1996) Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 143:11651172.
  • Friederichs V, Cameron JC, Robertson C. (2006) Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987–2004. Arch Dis Child 91:465468.
  • Gale JL, Thapa PB, Wassilak SG, Bobo JK, Mendelman PM, Foy HM. (1994) Risk of serious acute neurological illness after immunization with diphtheria-tetanus-pertussis vaccine. A population-based case-control study. JAMA 271:3741.
  • Geier DA, Geier MR. (2004) An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain Dev 26:296300.
  • Gitiaux C, Poeyo S, Demazes S, Pedespan L, Pillet P, Husson M, Pedespan J-M. (2006) Vaccinal status in children with seizures: a retrospective study conducted in the Bordeaux child hospital. Arch Pediatr 13:11021106.
  • Gold M, Goodwin H, Botham S, Burgess M, Nash M, Kempe A. (2000) Re-vaccination of 421 children with a past history of an adverse vaccine reaction in a special immunisation service. Arch Dis Child 83:128131.
  • Gold M, Dugdale S, Woodmanc RJ, McCaul KA. (2010) Use of the Australian childhood immunisation Register for vaccine safety data linkage. Vaccine 28:43084311.
  • Goodman M, Lamm SH, Bellman MH. (1998) Temporal relationship modeling: DTP or DT immunizations and infantile spasms. Vaccine 16:225231.
  • Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. (1990) Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine. JAMA 263:16411645.
  • Guggenheim MA, Frost JD, Hrachovy RA. (2008) Time interval from a brain insult to the onset of infantile spasms. Pediatr Neurol 38:3437.
  • Guida alle controndicazioni alle vaccinazioni. (2005) 3° edizione maggio. Istituto Superiore di Sanità.
  • Huang WT, Gargiullo PM, Broder KR, Weintraub ES, Iskander JK, Klein NP, Baggs JM, for the Vaccine Safety Datalink Team. (2010) Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics 126:263269.
  • Ishikawa T, Ogino C, Chang S. (1999) Lennox-Gastaut syndrome after a further attenuated live measles vaccination. Brain Dev 21:563565.
  • Jackson LA, Carste BA, Malais D, Froeschle J. (2002) Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Pediatr Infect Dis J 21:781785.
  • Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, Xie F, Cheetham TC, Saddier P. (2009) Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 27:46564661.
  • Jefferson T, Price D, Demicheli V, Bianco E, for the European Research Program for Improved Vaccine Safety Surveillance (EUSAFEVAC) Project. (2003) Unintended events following immunization with MMR: a systematic review. Vaccine 21:39543960.
  • Kerdpanich A, Warachit B, Kosuwon P, Gatchalian SR, Watanaveeradej V, Borkird T, Kosalaraksa P, Han HH, Hutagalung Y, Boutriau D, Dobbelaere K. (2008) Primary vaccination with a new heptavalent DTPw—HBV/Hib—Neisseria meningitidis serogroups A and C combined vaccine is well tolerated. Int J Infect Dis 12:8897.
  • Kimmel SR. (2002) Vaccine adverse events: separating myth from reality. Am Fam Physician 66:21132120.
  • Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E, Vaccine Safety Datalink. (2010) Measles-mumps-rubella-varicella combinationvaccine and the risk of febrile seizures. Pediatrics 126:e1e8.
  • Kohl KS, Marcy SM, Blum M, Jones MC, Dagan R, Hansen J, Nalin D, Rothstein E, Brighton Collaboration Fever Working Group. (2004) Fever after immunization: current concepts and improved future scientific understanding. Clin Infect Dis 39:389394.
  • Kroger AT, Atkinson WL, Marcuse EK, Pickering LK; **Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). (2006) General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55:148.
  • Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S; Canadian Paediatric Society/ Health Canada Immunization Monitoring Program–Active (IMPACT). (2003) Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 112:e348e353.
  • Marin M, Broder KR, Temte JL, Snider DE, Seward JF; **Centers for Disease Control and Prevention (CDC). (2010) Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59:112.
  • McIntosh AM, McMahon J, Dibbens LM, Iona X, Mulley JC, Scheffer IE, Berkovic SF. (2010) Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study. Lancet Neurol 9:592598.
  • McMahon AM, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, Ball R. (2005) Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event. Pediatrics 115:453460.
  • Miller D, Madge N, Diamond J, Wadsworth J, Ross E. (1993) Pertussis immunisation and serious acute neurological illnesses in children. BMJ 307:11711176.
  • Miller E, Andrews N, Stowe J, Grant A, Waight P, Taylor B. (2007) Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom. Am J Epidemiol 165:704709.
  • Moore DL, Le Saux N, Scheifele D, Halperin SA, Members of the Canadian Paediatric Society/Health Canada Immunization Monitoring Program, Active (IMPACT). (2004) Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993–2002. Pediatr Infect Dis J 23:568571.
  • Moreira Gomes Monteiro SA, Takanoa OA, Waldmanb EA. (2010) Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting. Vaccine 28:31273133.
  • Neville B. (2010) Dravet syndrome and ‘immunization encephalopathy. Dev Med Child Neurol 52:590591.
  • PNLG (Programma nazionale per le linee guida). (2002) Manuale Metodologico. Come produrre, diffondere e aggiornare raccomandazioni per la pratica clinica. Istituto Superiore Di Sanità, maggio 2002.
  • Poland GA, Ovsyannikova IG, Jacobson RM.. Adversomics: (2009) The emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J 28:431432.
  • Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, Shinefield H, Marcy M, Huff K, Ward J, Mullooly J, Chen R, Davis R, Vaccine Safety Datalink Group. (2006) Encephalopathy after whole-cell pertussis or measles vaccination. Lack of evidence for a causal association in a retrospective case–control study. Pediatr Infect Dis J 25:768773.
  • Reyes IS, Hsieh DT, Laux LC, Wilfong AA. (2011) Alleged cases of vaccine encephalopathy rediagnosed years later as Dravet syndrome. Pediatrics 128:e699e702.
  • Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM. (2009) Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age. Vaccine 27:42784283.
  • Salisbury D, Ramsay M, Noakes K. (2006) Immunisation against infectious disease. In: The green book. Published by The Stationery Office under licence from the Department of Health, London.
  • Sell E, Minassian BA. (2006) Demystifying vaccination-associated encephalopathy. Lancet Neurol 5:465466.
  • Shafrir Y. (2010) Vaccination and Dravet syndrome. Lancet Neurol 9:11471148.
  • Shorvon S, Berg A. (2008) Pertussis vaccination and epilepsy—an erratic history, new research and the mismatch between science and social policy. Epilepsia 49:219225.
  • Shui IM, Shia P, Maya Dutta-Linna M, Weintraub ES, Hambidge SJ, Nordine JD, Lieu TA, for the Vaccine Safety Datalink Research Team. (2009) Predictive value of seizure ICD9 codes for vaccine safety research. Vaccine 27:53075312.
  • SIGN 50. (2008) A Guideline Developer's Handbook. Scottish Intercollegiate Guidelines Network. Revised Edition January 2008.
  • Stehr-Green P, Radke S, Kieft C, Galloway Y, McNicholas A, Reid S. (2008) The risk of simple febrile seizures after immunisation with a new group B meningococcal vaccine, New Zealand. Vaccine 26:739742.
  • Sugai K. (2010) Current management of febrile seizures in Japan: an overview. Brain Dev 32:6470.
  • Sun Y, Christensen J, Hviid A, Li J, Vedsted P, Olsen J, Vestergaard M. (2012) Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type B. JAMA 307:823831.
  • Sweet M. (2010) Australian health authorities’ response criticised after adverse events related to influenza vaccination in children. BMJ 341:c4470.
  • Tanabe T, Awaya Y, Matsuishi T, Nagai T, Yamamoto K, Kurihara M, Iyoda K, Maekawa K. (2004) Survey of vaccination and viral infections for children with severe myoclonic epilepsy in infancy. No To Hattatsu 36:318323.
  • Tro-Baumann B, von Spiczak S, Lotte J, Bast T, Haberlandt E, Sassen R, Freund A, Leiz S, Stephani U, Boor R, Holthausen H, Helbig I, Kluger G. (2011) A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome. Epilepsia 52:175178.
  • Turcotte K, Raina P, Moyer WA. (2001) Above all, do no harm. Assessing the risk of an adverse reaction. West J Med 174:325329.
  • U.S. Institute of Medicine. (1985). Adverse events associated with pertussis and rubella vaccines. National Academy Press, Washington DC.
  • U.S. Institute of Medicine. (1994). DPT vaccine and chronic nervous system dysfunction: a new analysis. National Academy Press, Washington DC.
  • Varricchio F, Iskander J, DeStefano F, Ball ??, Pless R, Braun M, Chen RT. (2004) Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23:287294.
  • Vestergaard M, Christensen J. (2009) Register-based studies on febrile seizures in Denmark. Brain Dev 31:372377.
  • Vestergaard M, Hviid A, Madsen KM, Wohlfahrt J, Thorsen P, Schendel D, Melbye M, Olsen J. (2004) MMR vaccination and febrile seizures evaluation of susceptible subgroups and long-term prognosis. JAMA 292:351357.
  • Von Spiczak S, Helbig I, Drechsel-Baeuerle U, Muhle H, Van Baalen A, Van Kempen MJ, Lindhout D, Scheffer IE, Berkovic SF, Stephani U, Keller-Stanislawski B. (2011) A retrospective population-based study on seizures related to childhood vaccination. Epilepsia 52:15061512.
  • Ward KN, Bryant NJ, Andrews NJ, Bowley JS, Ohrling A, Verity CM, Ross EM, Miller E. (2007) Risk of serious neurologic disease after immunization of young children in Britain and Ireland. Pediatrics 120:314321.
  • Wharton M. (2010) Vaccine safety: current systems and recent findings. Curr Opin Pediatr 22:8893.
  • Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, Miles Braun MM. (2004) Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA 292:17021710.
  • Wisnitzer M. (2010) Dravet syndrome and vaccination: when science prevails over speculation. Lancet Neurol 9:559561.
  • Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI. (2008) A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization. Pediatrics 122:e1179e1185.